GEM HEALTH removes the frustration of not knowing where to start or the next steps when navigating a new condition. GEM's first product, GEM SLEEP, helps the estimated 30 million people with obstructive sleep apnea find relief. GEM provides a simple guided experience through diagnosis, treatment, and ongoing support, reducing the time to relief from months to weeks. GEM SLEEP treats patients in 50 states and is in-network with 53 million Americans' health plans ensuring broad access to care.
Date | Amount | Type | Investors | Valuation |
---|---|---|---|---|
03/04/25 | $7,000,000 | Series A |
Base10 Partners HealthTrend Capital ![]() LFE Capital ![]() Mairs & Power | undisclosed |